Reuters
@Reuters·4.2M subscribers·86.9K videos
GSK shares tumble 9% after Zantac ruling | REUTERS
Posted
June 3, 2024
Views
1,806
Likes
35
Engagement
1.94%
June 3, 2024
1,806
35
1.94%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:08Now PlayingShares of GSK dropped more than 9% after a Delaware judge allowed more than 70,000 lawsuits alleging its discontinued heartburn drug Zantac caused cancer, to go forward, in a blow for the British drugmaker.
#News #GSK #USA #UK #Zantac #Reuters #Newsfeed
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
